Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
anti-mesothelin car-t cells | mesothelin | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Stomach[MeSHID:D013270] Malignant neoplasm of pancreas[MeSHID:D010190] Adenocarcinoma[MeSHID:D000230] Pancreatic carcinoma[MeSHID:C562463] Cells[MeSHID:D002477] Mesothelioma[MeSHID:D008654] |
NA | phase 1 | unknown |
anti-mesothelin car-t cells | mesothelin | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Cells[MeSHID:D002477] |
NA | phase 1 | unknown |
anti-mesothelin car-t cells | mesothelin | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Stomach[MeSHID:D013270] Malignant neoplasm of pancreas[MeSHID:D010190] Adenocarcinoma[MeSHID:D000230] Pancreatic carcinoma[MeSHID:C562463] Cells[MeSHID:D002477] Mesothelioma[MeSHID:D008654] |
NA | phase 1/2 | unknown |
anti-mesothelin car-t cells | mesothelin | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Cells[MeSHID:D002477] |
NA | phase 1/2 | unknown |
click here to return to the previous page |